🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 día
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/11/2013 | 88,79 | 90,44 | 88,02 | 90,34 | +2,06% | 2,73% | 781.200 |
| 31/10/2013 | 86,52 | 89,08 | 86,25 | 88,52 | +2,24% | 3,27% | 933.200 |
| 30/10/2013 | 87,27 | 87,45 | 85,31 | 86,58 | +0,09% | 2,45% | 720.400 |
| 29/10/2013 | 85,06 | 87,50 | 83,65 | 86,50 | +3,73% | 4,53% | 1.053.900 |
| 28/10/2013 | 82,36 | 83,60 | 81,83 | 83,39 | +0,90% | 2,15% | 417.600 |
| 25/10/2013 | 83,87 | 83,96 | 81,60 | 82,65 | -0,99% | 2,81% | 364.500 |
| 24/10/2013 | 83,31 | 84,35 | 83,02 | 83,48 | +0,78% | 1,60% | 446.100 |
| 23/10/2013 | 82,50 | 83,47 | 82,00 | 82,83 | +0,28% | 1,78% | 554.800 |
| 22/10/2013 | 81,74 | 83,22 | 81,26 | 82,60 | +1,82% | 2,40% | 418.600 |
| 21/10/2013 | 82,78 | 83,25 | 80,77 | 81,12 | -1,64% | 3,00% | 577.400 |
| 18/10/2013 | 82,68 | 82,99 | 81,15 | 82,47 | +0,56% | 2,23% | 449.900 |
| 17/10/2013 | 81,01 | 82,64 | 80,51 | 82,01 | +0,33% | 2,63% | 468.500 |
| 16/10/2013 | 81,56 | 81,99 | 80,97 | 81,74 | +1,30% | 1,25% | 562.100 |
| 15/10/2013 | 81,80 | 82,14 | 80,48 | 80,69 | -1,48% | 2,03% | 306.700 |
| 14/10/2013 | 81,55 | 82,40 | 80,79 | 81,90 | +0,13% | 1,97% | 336.500 |
| 11/10/2013 | 81,36 | 82,56 | 80,95 | 81,79 | +0,38% | 1,98% | 653.200 |
| 10/10/2013 | 81,47 | 83,54 | 81,02 | 81,48 | +1,81% | 3,09% | 594.100 |
| 09/10/2013 | 81,29 | 82,10 | 78,14 | 80,03 | -1,77% | 4,87% | 702.100 |
| 08/10/2013 | 85,40 | 85,65 | 81,18 | 81,47 | -4,24% | 5,23% | 946.500 |
| 07/10/2013 | 84,25 | 85,57 | 83,52 | 85,08 | -0,47% | 2,43% | 491.100 |
| 04/10/2013 | 85,06 | 85,92 | 84,37 | 85,48 | +0,96% | 1,82% | 547.700 |
| 03/10/2013 | 83,15 | 85,27 | 83,15 | 84,67 | +1,20% | 2,55% | 1.143.900 |
| 02/10/2013 | 82,01 | 83,74 | 81,51 | 83,67 | +1,69% | 2,72% | 727.500 |
| 01/10/2013 | 79,00 | 82,36 | 78,40 | 82,28 | +4,35% | 5,01% | 1.479.600 |
| 30/09/2013 | 77,78 | 79,02 | 77,22 | 78,85 | +0,17% | 2,31% | 443.400 |
| 27/09/2013 | 78,71 | 79,90 | 77,95 | 78,72 | -0,30% | 2,48% | 279.500 |
| 26/09/2013 | 77,58 | 79,16 | 77,14 | 78,96 | +2,25% | 2,60% | 327.800 |
| 25/09/2013 | 77,50 | 77,79 | 76,02 | 77,22 | +0,08% | 2,28% | 394.000 |
| 24/09/2013 | 77,40 | 77,81 | 76,20 | 77,16 | -0,31% | 2,08% | 229.000 |
| 23/09/2013 | 78,04 | 78,36 | 77,04 | 77,40 | -0,59% | 1,69% | 297.400 |